All journal publications

Found 7 results. Export: Tagged | XML
Filters: author is Sauerborn  [Clear All Filters]
2014
Torosantucci, R., Brinks, V., Kijanka, G., Halim, L.A., Sauerborn, M., Schellekens, H., Jiskoot, W. , Development of a Transgenic Mouse Model to Study the Immunogenicity of Recombinant Human Insulin, Journal of pharmaceutical sciences, vol. 103, issue 5, pp. 1367–1374. DOI
2013
Sauerborn, M., van Beers, M.M., Jiskoot, W., Kijanka, G.M., Boon, L., Schellekens, H., Brinks, V. , Antibody Response Against Betaferon(R) in Immune Tolerant Mice: Involvement of Marginal Zone B-cells and CD4+ T-cells and Apparent Lack of Immunological Memory, J Clin Imm, vol. 33, no. 1, pp. 255-63. DOI
2011
van Beers, M.M., Sauerborn, M., Gilli, F., Brinks, V., Schellekens, H., Jiskoot, W. , Oxidized and Aggregated Recombinant Human Interferon Beta is Immunogenic in Human Interferon Beta Transgenic Mice, Pharm Res, vol. 28, no. 10, pp. 2393-402. DOI
2010
van Beers, M.M., Sauerborn, M., Gilli, F., Brinks, V., Schellekens, H., Jiskoot, W. , Aggregated Recombinant Human Interferon Beta Induces Antibodies but No Memory in Immune-Tolerant Transgenic Mice, Pharm Res, vol. 27, issue 9, pp. 1812-1824. DOI
van Beers, M.M., Sauerborn, M., Gilli, F., Hermeling, S., Brinks, V., Schellekens, H., Jiskoot, W. , Hybrid transgenic immune tolerant mouse model for assessing the breaking of B cell tolerance by human interferon beta, J Immunol Methods, vol. 352, no. 1-2, pp. 32-7. DOI
Sauerborn, M., Brinks, V., Jiskoot, W., Schellekens, H. , Immunological mechanism underlying the immune response to recombinant human protein therapeutics, Trends Pharmacol Sci, vol. 31, no. 2, pp. 53-9. DOI
2008
Sauerborn, M., van Beers, M., Jiskoot, W., Schellekens, H. , Immunogenicity of therapeutic proteins: A 'classical' break of tolerance?, Wiener Klinische Wochenschrift, vol. 120, pp. 123-123.